Massachusetts House Bill H4014

Massachusetts 2025-2026 Regular Session

• Introduced: 4/10/25
• Refer: 4/10/25

Caption

Authorizing pharmacists to provide opioid use disorder treatment

Impact

By permitting pharmacists to offer and be reimbursed for opioid use disorder treatment, H4014 is expected to significantly expand the healthcare options available to patients. The amendments would ensure that insurance policies provide coverage for such collaborative drug therapy, aligning pharmacists' roles with that of other healthcare providers. This measure could potentially increase the number of trained professionals available to manage and treat opioid use disorders, thereby addressing a critical public health challenge within the state.

Summary

House Bill 4014 aims to authorize pharmacists in Massachusetts to provide treatment for opioid use disorder. The bill proposes amendments to several chapters of the General Laws to facilitate collaborative drug therapy services rendered by licensed pharmacists. Under the new provisions, pharmacists will be reimbursed for these services at a rate comparable to that of other non-physician practitioners. This legislation seeks to enhance treatment access for individuals battling opioid addiction, empowering pharmacists to play a crucial role in providing necessary healthcare services.

Contention

While the bill introduces a progressive approach to managing opioid addiction treatment, it may spark debate over the qualifications and scope of practice for pharmacists. Critics might voice concerns about ensuring that pharmacists are adequately trained for this role and whether they can provide the necessary level of care typically associated with specialized healthcare providers. Additionally, the integration of pharmacists into the treatment landscape for opioid use disorders raises questions about the overall coordination of care and the effectiveness of such collaborative practices in improving patient outcomes.